Protocol identity, status, enrollment, dates, endpoints, and results-posting status
In June 2021, the agency approved Wegovy (semaglutide 2.4 mg once weekly) for weight management in adults with a body mass index (BMI) of 30 kg/m or greater (obesity), or a BMI of 27 kg/m or greater (overweight) with at least one weight-related comorbidity such as hypertension, dyslipidemia, or obstructive sleep apnea
Your doctor will guide you on the proper washout period and starting dose to manage tolerance and potential side effects, ensuring a safe transition in your drug administration schedule
How AOD-9604 compares with related compounds and approved drugs
Cat.#: 300019 * Buy 1 get 1 free (?) Special Price 153.60 USD Product Information Product Name Phospho DSIP peptide Documents Batch to batch variation of the purity Sequence Shortening WAGGDASGE, S=Phospho Serine Sequence H-Trp-Ala-Gly-Gly-Asp-Ala-Ser(PO3H2)-Gly-Glu-OH Length (aa) 9 Peptide Purity (HPLC) 95.14% Molecular Formula C 35 H 49 N 10 O 18 P 1 Molecular Weight 928.81 CAS No